Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials Of Gefapixant, A P2x3 Receptor Antagonist, In Refractory Or Unexplained Chronic Cough (Cough-1 And Cough-2)
EUROPEAN RESPIRATORY JOURNAL（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要